Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study: Ranjit Mohan Anjana et al, Lancet Diabetes
New Delhi, February 13, 2018: Sanofi Indiacontinues to deliver breakthrough medicines for the management of diabetes with the launch of its new product – Toujeo™,the next generation basal insulin. Toujeo™ is a once-daily,long-actingbasal analog insulin that improves glycemic control in adults with type 1 and type 2 diabetes.
Corporate Comm India(CCI Newswire)
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…